Gwynedd Mercy University Names New Vice President for Finance and CFO
GWYNEDD VALLEY, Pa.–(BUSINESS WIRE)–Gwynedd Mercy University has named Heather L. Meier, CPA as its next…
GWYNEDD VALLEY, Pa.–(BUSINESS WIRE)–Gwynedd Mercy University has named Heather L. Meier, CPA as its next…
Analysts Discuss the Outlook for the Global IT Market During Gartner IT Symposium/Xpo 2022, October…
KILGORE, Texas–(BUSINESS WIRE)–Martin Midstream Partners L.P. (NASDAQ: MMLP) (“MMLP” or the “Partnership”) announced today that,…
New high-efficiency yard light in a slim design features 3000K, 4000K and 5000K color selectable…
Inspur’s four open servers newly certified as OCP Inspired™ products SAN JOSE, Calif.–(BUSINESS WIRE)–Inspur Information,…
Cassie Jackson, Marcus Davis and Charlotte Ketelaar will fuel the firm’s growth as it adds…
Agreement will allow researchers to streamline development of on-demand and automated production of CRISPR-Cas9 guide…
Further Demonstrating Possibilities for Systemic Delivery of Large Molecules SAN DIEGO, Oct. 19, 2022 (GLOBE…
Figure: 1 Compound F3 and enhanced activity derivative F3-8-60 directly bind to K-RAS Figure: 2…
SAN FRANCISCO, Oct. 19, 2022 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage…
HOUSTON, Oct. 19, 2022 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical…
CAMBRIDGE, Mass., Oct. 19, 2022 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage…
Exclusive license from Helmholtz Munich will enable ITM to access IP and know-how to develop…
WARREN, N.J., Oct. 19, 2022 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical…
PTX-COVID19-B was well tolerated with no safety signals Non-inferior neutralizing antibody titer levels versus comparator…
SEATTLE, Oct. 19, 2022 (GLOBE NEWSWIRE) — Umoja Biopharma, Inc., an immuno-oncology company pioneering off-the-shelf,…
The PMDA enters 9th consecutive year of using Certara’s software PRINCETON, N.J., Oct. 19, 2022…
Dr. Mark Lowdell, CSO, Presented Latest Data in First Plenary Session at The Innate Killer…
Phase 2 investigator-initiated trial to be supported by an NCI grant to Providence Cancer Institute…
EDISON, N.J., Oct. 19, 2022 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage…